Molten Ventures Plc (GRWXF)
| Market Cap | 908.05M |
| Revenue (ttm) | 56.33M |
| Net Income (ttm) | -1.03M |
| Shares Out | n/a |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | 10.45 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 500 |
| Average Volume | 1,159 |
| Open | 4.850 |
| Previous Close | n/a |
| Day's Range | 4.850 - 4.850 |
| 52-Week Range | 3.510 - 5.650 |
| Beta | 1.24 |
| RSI | 56.28 |
| Earnings Date | Nov 25, 2025 |
About Ligand Pharmaceuticals
Molten Ventures Plc, formerly known as Draper Esprit plc, is a private equity and venture capital firm specializing in directly investing as well as investing in other funds. In direct investments, the firm invests in any stage in the lifecycle of a business from seed, early stage, later stage, later venture, and series A stage, mature, growth capital, pre-IPO investments, IPO or acquisition, late stage, start-ups, cross-stage investments, buyouts, PIPES, and also makes direct and secondary investments in portfolio companies. It also seeks to... [Read more]
Financial Performance
Financial StatementsNews
MIDAS SHARE TIPS: Taking a punt on Molten Ventures could be sure-fire winner
Molten shares are not for the cautious but adventurous investors looking to support UK technology firms could buy into this stock.
Half-year report
Molten Ventures VCT plc LEI: 2138003I9Q1QPDSQ9Z97 Half - Year Report 9 December 2022
Dublin-based corporate gifting platform &Open raises $26M Series A led by Molten Ventures
Last year we covered how “&Open” (yes, “ampersand open,” pronounced “And Open”) had raised a raised $7.2 million seed to make it easier for brands to send gifts to customers to boost loyalty and engag...